IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.08-2625 on September 29, 2008
 (Investigative Ophthalmology and Visual Science. 2009;50:573-576.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2625
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2625v1
50/2/573    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breusegem, C.
Right arrow Articles by Zeyen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breusegem, C.
Right arrow Articles by Zeyen, T.

Predictive Value of a Topical Dexamethasone Provocative Test before Intravitreal Triamcinolone Acetonide Injection

Christophe Breusegem, Evelien Vandewalle, Joachim Van Calster, Ingeborg Stalmans, and Thierry Zeyen

From the Department of Ophthalmology, Leuven University Hospitals, Leuven, Belgium.

PURPOSE. To investigate the diagnostic value of a topical dexamethasone (DXM) provocative test before intravitreal triamcinolone acetonide (IVTA) injection for a steroid response.

METHODS. Eligible patients scheduled for first-time IVTA who did not have glaucoma or a history of a steroid response received DXM 0.1% drops 4 times daily over 4 weeks. After that, IVTA was given except in DXM responders with an IOP increase greater than 15 mm Hg. IOP was measured at baseline, 4 weeks after DXM treatment, at weeks 1, 2, and 4, and at months 3 and 6 after IVTA. A steroid response after the DXM test or after IVTA was defined as an IOP increase of 6 mm Hg or greater.

RESULTS. Thirty-six patients (36 eyes) were analyzed. The DXM test had a sensitivity of 25% (95% confidence interval [CI], 0.07–0.52), a specificity of 100% (95% CI, 0.83–1.00), a positive predictive value of 100% (95% CI, 0.40–1.00), and a negative predictive value of 62% (95% CI, 0.44–0.79) for a steroid response after IVTA. In DXM responders, the IOP increase after IVTA was 17.0 ± 7.8 mm Hg versus 5.0 ± 4.4 mm Hg in DXM nonresponders (P = 0.005). The IOP increase after the DXM test correlated with the IOP increase after IVTA (P = 0.001).

CONCLUSIONS. The topical DXM test had a low sensitivity, a high specificity, a high positive predictive value, and a moderate negative predictive value and may be useful to predict a steroid response after IVTA. DXM responders demonstrated high IOP increases after IVTA, and the IOP increase after the DXM test correlated with the IOP increase after IVTA. If the DXM test result is positive, risks and benefits of IVTA should be more carefully weighted.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology